DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model

<p>Aims: To explore the cost-effectiveness of alternative methods of screening family members for hypertrophic cardiomyopathy (HCM), the most common monogenic cardiac disorder and the most frequent cause of sudden cardiac death (SCD) in young people.</p><p>Methods and results: Econ...

Full description

Bibliographic Details
Main Authors: Wordsworth, S, Leal, J, Blair, E, Legood, R, Thomson, K, Seller, A, Taylor, J, Watkins, H
Other Authors: The European Society of Cardiology
Format: Journal article
Language:English
Published: Oxford University Press 2010
Subjects: